Posts

Showing posts with the label what is pulmonary hypertension

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension - Pulmonology Advisor

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows - Pulmonary Hypertension News

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows    Pulmonary Hypertension News Top-line results of a Phase 2b clinical trial of Bellerophon's INOpulse in patients with PH associated with ILD showed improvements in physical activity.

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair? - Pulmonology Advisor

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair?    Pulmonology Advisor In patients undergoing transcatheter mitral valve repair (TMVR) with the Mitraclip device, pre-existing pulmonary hypertension (PH) is not associated with ...

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease - The Cardiology Advisor

Societies Publish Appropriate Use Criteria for Multimodality Imaging in Nonvalvular Heart Disease    The Cardiology Advisor Updated appropriate use criteria addresses the use of multimodality imaging for evaluation of cardiac structure and function in nonvalvular heart disease.

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease - The Cardiology Advisor

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Deposit four-year-old awaits heart transplant in NYC - WBNG-TV

Deposit four-year-old awaits heart transplant in NYC    WBNG-TV The wait for a new heart has now passed 100 days for Jackson Vandermark, who was admitted to Morgan Stanley Children's Hospital in New York City on ...

Unexpected Growth Seen in Chronic Thromboembolic Pulmonary Hypertension Market - AlgosOnline

Unexpected Growth Seen in Chronic Thromboembolic Pulmonary Hypertension Market    AlgosOnline Market Study Reports recently added a detailed market research study focused on the Global Chronic Thromboembolic Pulmonary Hypertension Market across ...

Pulmonary Hypertension Drug Market 2019-2024 Depth Analysis By Novartis AG, Merck & Co., Abbott Laboratories, AstraZeneca plc - Bitcoin Journal

Pulmonary Hypertension Drug Market 2019-2024 Depth Analysis By Novartis AG, Merck & Co., Abbott Laboratories, AstraZeneca plc    Bitcoin Journal Global Pulmonary Hypertension Drug Market 2019 – 2024 SWAT Analysis. Global Pulmonary Hypertension Drug Market Research report presents a ...

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension - The Cardiology Advisor

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Team PHenomenal Hope Accepting Applications for Research Grants - Pulmonary Hypertension News

Team PHenomenal Hope Accepting Applications for Research Grants    Pulmonary Hypertension News To better the lives of pulmonary hypertension (PH) patients, Team PHenomenal Hope is taking applications for early-career research grants of up to $50000.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD - Pulmonology Advisor

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD    Pulmonology Advisor Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression ...

Chinese PH Patients Form Beijing-based Advocacy Group - Pulmonary Hypertension News

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System - Cath Lab Digest

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival - Medscape

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

Top 10 Pulmonary Hypertension Stories of 2018 - Pulmonary Hypertension News

Top 10 Pulmonary Hypertension Stories of 2018    Pulmonary Hypertension News The top 10 pulmonary hypertension (PH) stories of 2018 dealt primarily with new strategies to diagnose and treat the disease.

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients - Pulmonary Hypertension News

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients    Pulmonary Hypertension News Read about a study indicating that factors such as worse cardiac function are associated with obstructive sleep apnea in patients with CTEPH.